title: Canonical nuclear factor κB pathway links tumorigenesis of synchronous mantle-cell lymphoma, clear-cell renal-cell carcinoma, and GI stromal tumor.
authors.forename: Robin
authors.initials: R
authors.lastname: Guo
authors.forename: Lufen
authors.initials: L
authors.lastname: Chang
authors.forename: Zheng
authors.initials: Z
authors.lastname: Liu
authors.forename: Arthur X
authors.initials: AX
authors.lastname: Li
authors.forename: Qin
authors.initials: Q
authors.lastname: Huang
authors.forename: David K
authors.initials: DK
authors.lastname: Ann
authors.forename: Hao-Chien
authors.initials: HC
authors.lastname: Wang
authors.forename: Chung-Wu
authors.initials: CW
authors.lastname: Lin
authors.forename: Xiwei
authors.initials: X
authors.lastname: Wu
authors.forename: Yate-Ching
authors.initials: YC
authors.lastname: Yuan
authors.forename: Yun
authors.initials: Y
authors.lastname: Yen
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D055028:Comparative Genomic Hybridization; D003520:Cyclophosphamide / Q000008:administration & dosage; D016207:Cytokines / Q000097:blood; D013505:Digestive System Surgical Procedures; D004317:Doxorubicin / Q000008:administration & dosage; D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D018836:Inflammation Mediators / Q000097:blood; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D020522:Lymphoma, Mantle-Cell / Q000175:diagnosis / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D008297:Male; D016328:NF-kappa B / Q000235:genetics*; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D015398:Signal Transduction / Q000235:genetics*; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D016207:Cytokines; D018836:Inflammation Mediators; D016328:NF-kappa B; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone